Elizabeth B. Taylor - 22 Mar 2026 Form 4 Insider Report for Sanara MedTech Inc. (SMTI)

Reporting relationship: Chief Financial Officer
Issuer ticker: SMTI
Reported as of: 22 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 23 Mar 2026, 16:33:05 UTC
Prior SEC filing: 27 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Elizabeth B. Taylor

Key filing fact

Elizabeth B. Taylor filed Form 4 for Sanara MedTech Inc. (SMTI) on 23 Mar 2026.

Key facts

This page summarizes Elizabeth B. Taylor's Form 4 filing for Sanara MedTech Inc. (SMTI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 23 Mar 2026, 16:33.

Change

Previous filing in this sequence was filed on 27 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002052808 Primary reporting owner

Taylor Elizabeth B

Relationship: Chief Financial Officer
Address: 1200 SUMMIT AVE, SUITE 414, FORT WORTH
Signature: /s/ Elizabeth B. Taylor
Signature date: 23 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SMTI transaction

Common Stock

Award

Transaction value
Shares: -12,687
Change %: -42%
Price: $0.000000^*
Shares after: 17,632
Date: 22 Mar 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of restricted stock granted by Sanara MedTech Inc. (the "Issuer") to the reporting person pursuant to the Sanara MedTech Inc. 2024 Omnibus Long-Term Incentive Plan. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 22, 2027, 2028 and 2029, respectively, provided that the reporting person is employed by the Issuer through each such date.